Companies › DARE

Dare Bioscience Inc (DARE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001401914 · EDGAR filings · Updated 2026-07-24

Dare Bioscience Inc (DARE) has reported institutional ownership of 7.0%, with 26 institutional managers holding positions valued at $1.87M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — 253G2 filed
• 2026-07-17 — Current report (8-K) filed
• 2026-07-13 — Current report (8-K) filed
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Dare Bioscience Inc has 26 institutional holders and institutional ownership of 7.0%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

PURETECH HEALTH PLC (PRTCY) · BIOFRONTERA INC (BFRI) · CRYO-CELL INTL INC (CCEL) · Fresenius SE & Co KGaA (FSNUF) · NANOVIRICIDES INC (NNVC) · APREA THERAPEUTICS INC (APRE)